CAPILLARY
Capillary Announces Q4 Fy2026 Results With 26% Revenue Growth
Capillary Technologies India Limited reports 26% revenue growth for Q4 FY2026 and 23% for FY2026.
Capillary Technologies India Limited, a software product company, announced its financial results for the fourth quarter and full year ended March 31, 2026. The company reported strong revenue growth of 26% year-on-year for the quarter ended March 31, 2026 and 23% for the full year ended March 31, 2026. This growth was driven by expansion within the existing customer base, growth in new annual contract value contributions, and the focused integration of the Kognitiv business acquired in May 2025.
Quarterly Performance
For Q4 FY2026, compared to the same quarter last year, the company reported:
Operating Revenue of ₹ 1,913.5 Mn. vs. ₹ 1,520.8 Mn. (+26% YoY)
Adjusted EBITDA of ₹ 357.2 Mn. vs. ₹ 278.4 Mn. (+28% YoY)
PAT of ₹ 433.6 Mn. vs. ₹ 130.2 Mn. (233% YoY)
Full Year Performance
For FY2026, compared to the same period last year, the company reported:
Operating Revenue of ₹ 7,346.0 Mn. vs. ₹ 5,982.6 Mn. (+23% YoY)
Adjusted EBITDA of ₹ 1069.2 Mn. vs. ₹ 745.1 Mn. (+43% YoY)
PAT of ₹ 523.9 Mn. vs. ₹ 141.5 Mn. (+270% YoY)
Commenting on Q4 FY2026 results, Aneesh Reddy Boddu, Founder, MD & CEO, said, “We delivered a strong quarter, driven by Net Retention Rate (NRR) expansion, the continued addition of large enterprise clients globally, and early integration synergies from the Kognitiv acquisition. The successful closure of the SessionM acquisition from Mastercard further strengthens our market position, providing access to a prestigious portfolio of Fortune 500 brands. Our proprietary AI platform, aiRA, is gaining traction, and we are actively leveraging AI to streamline customer migrations, and drive enterprise-wide productivity within Capillary. Moving forward, we remain committed to sustainable organic growth and profitability while prioritizing the seamless integration of SessionM’s team and clientele”.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Infrastructure sector. Here’s a quick read on where the business and the stock stand today.
Capillary falls 11.4% over three months and has not found a floor yet. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. Buyers show up with 2.4x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. Revenue grows at 53.1% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited Q2 Fy2027: Operating Revenue Up 51% Yoy
Capillary Technologies India Limited (CAPILLARY) reports 51% YoY growth in operating revenue for Q2 FY2027, with 103% growth in Adjusted EBITDA.
Capillary Technologies India Limited (CAPILLARY) announced its financial results for the second quarter and half year ended September 30, 2026. The company reported strong revenue growth of 51% year-on-year (43% in constant currency) and 103% growth in Adjusted EBITDA for the quarter ended September 30, 2026. This growth reflects strong expansion across existing customers, rising contributions from new annual contract value, and the inclusion of revenues from SessionM, Capillary’s most recent acquisition completed in May 2026.
Quarterly Performance
For Q2 FY2027, compared to the same quarter last year, the company reported:
- Operating Revenue of ₹ 2,713.5 Mn. vs. ₹ 1,793.3 Mn. (+51% YoY; +43% YoY CC)
- Adjusted EBITDA of ₹ 448.6 Mn. vs. ₹ 220.8 Mn. (+103% YoY)
- PAT of ₹ 219.2 Mn. vs. ₹ 2.9 Mn. (+7,505% YoY)
Half-Year Performance
For H1 FY2027, compared to the same period last year, the company reported:
- Operating Revenue of ₹ 5,280.0 Mn. vs. ₹ 3,592.2 Mn. (+47% YoY; +38% YoY CC)
- Adjusted EBITDA of ₹ 888.8 Mn. vs. ₹ 410.6 Mn. (+116% YoY)
- PAT of ₹ 123.7 Mn. vs. ₹ 10.3 Mn. (+1,097% YoY)
Commenting on Q2 FY2027 results, Aneesh Reddy Boddu, Founder, MD & CEO, said, “We delivered another strong quarter, driven by continued Net Revenue Retention (NRR) expansion and new enterprise wins across global markets. SessionM, which we acquired from Mastercard last quarter, is performing as planned and has achieved breakeven; our integration plans are on track. Artificial Intelligence has become a major tailwind for our business with aiRA and our broader AI capabilities underpinning key new ACV wins this quarter which are up 79% YoY on a TTM basis (excluding an exceptional new contract value from our first entry into the healthcare vertical). We also completed our first customer migration using our AI-powered migration technology, which positions us to move acquired customers onto the Capillary platform faster and more efficiently. We are seeing strong momentum in our Order book across Geographies. Looking ahead, we remain focused on sustainable organic growth and profitability, while scaling AI across our platform, our customer migrations and our own operations.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary rises 11.0% over three months, with buying pressure holding steady. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock holds at 30% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited (capillary) Appoints Bill Swift as President, Americas
Capillary Technologies India Limited (CAPILLARY) appoints Bill Swift as President, Americas, strengthening its US leadership and growth strategy.
Capillary Technologies India Limited (CAPILLARY) announced the appointment of Bill Swift as President, Americas, on October 29, 2026. This strategic move underscores Capillary’s commitment to deepening its presence across the Americas. Swift brings nearly 30 years of experience in helping leading brands build lasting customer relationships and drive measurable business results.
Leadership Expertise
Swift previously served as CEO of Brierley, a company that pioneered in loyalty solutions. His role at Brierley+Partners, where he helped create a successful loyalty platform, has equipped him with deep insights into loyalty strategies. Since joining Capillary in 2023, Swift has been instrumental in integrating acquisitions and shaping Capillary’s growth trajectory.
Strategic Vision for Americas
In his new role, Swift will lead Capillary’s business operations across the Americas, focusing on sales, client success, and delivery. He aims to drive growth with enterprise brands in retail, hospitality, travel, airlines, and other major sectors. Swift emphasizes that loyalty should be viewed as a catalyst for growth, facilitated by technology that delivers powerful customer experiences and business results.
“Loyalty has always been about earning the right to a lasting relationship with the customer,” said Bill Swift. “The most successful brands now see loyalty as a catalyst for growth, driven by technology that delivers real business results.”
Anant Choubey, co-founder & COO of Capillary, highlighted Swift’s strategic depth and understanding of customer relationships, stating, “His leadership was essential to Brierley+Partners’ success, and he is the right leader to accelerate our growth across the Americas.”
Founded in 2012, Capillary Technologies helps brands leverage lasting customer relationships to achieve measurable growth. Its AI-powered platform integrates loyalty, data, and engagement to deliver personalized experiences, strengthening retention and growing customer lifetime value.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary rises 11.0% over three months, with buying pressure holding steady. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock holds at 30% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) eases after clearing resistance, down 5% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) shows pressure after breakout, moving down 5% intraday.
Capillary Technologies India Limited (CAPILLARY) pulls back from breakout highs, falling 5% to ₹530.4 on the NSE today. This retracement comes after the stock cleared a crucial 6-month resistance level at ₹512, marking a structural breakout. The pullback today is likely due to profit-taking following this breakout. Capillary Technologies operates in the technology sector, specifically in software infrastructure. Today’s move appears to be company-specific rather than a sector-wide trend, as it follows the breakout and subsequent profit-taking.
Technical setup — trendlines & DMA
The current 6-month trendline structure shows a breakout above the resistance level at ₹512, with the stock now trading 3.5% above this resistance. The 6-month support trendline is at ₹464.21, which is 12.48% below today’s price. The stock is currently trading 11% above the 50-day moving average (DMA) at ₹505.2, indicating an extended move. However, it is slightly below the 200-DMA at ₹560.7. The stock is in the lower third of its 52-week range, trading 20% above the 52-week low and 33.6% below the 52-week high, suggesting there is still room for further upside within the year.
Snapshot: ₹530.40 on 2026-08-10 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 81.7 and profit margins at 5.2%, Capillary Technologies is trading at a high valuation relative to its current earnings. The revenue CAGR of 34.0% indicates strong growth, but the thin profit margins suggest that the market may be pricing in future improvements or a potential turnaround. The 20.6% institutional ownership suggests that smart money has a moderate level of confidence in the company, though it is not overwhelmingly bullish. There is no NSE catalyst today, so the move is primarily technical.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically strong but fundamentally weak position for Capillary Technologies. The strongest signals include the revenue and profit CAGRs, which are excellent at 34.0% and 27.0%, respectively, indicating robust growth. Additionally, the very low debt level with a D/E ratio of 0.00 points to excellent financial health. On the weaker side, the low profit margin of 5.2% leaves little room for error, and the PEG ratio of 3.03 suggests the stock is overvalued relative to its growth rate. The negligible dividend yield also means there is little to no income generation from this investment.
Company outlook
Management expects EBITDA margins to remain sustainable, with a potential dip due to the SessionM acquisition. The core organic business is projected to reach a steady-state EBITDA margin of 25-30%. Revenues are anticipated to exceed INR 1,000-1,050 crores in FY27, driven by both the SessionM acquisition and organic growth. SessionM is expected to significantly contribute to revenue growth and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
-
HIRECT2 days agoHirect Limited Q2 & H1 FY27: Highest-ever Revenue, Strong Business Momentum
-
Consumer Cyclical2 days agoKalyan Jewellers India Limited (kalyankjil) Q2 FY27: Revenue Surpasses Rs 10,300 Crore, PAT Rises 64%
-
Basic Materials2 days agoVishnu Chemicals Limited Q2fy27: Strategic JV with DCX Chrome SAS, Ebitda Grows 10% Yoy
-
Auto Parts2 days agoTvs Srichakra Limited (tvssrichak) Anticipates Late Announcement: Exploring the Intrigue
-
Credit Services2 days agoIifl Finance Limited to Raise ₹6,414 Crores ($686 Million) in Major Private Equity Infusion
-
Basic Materials2 days agoJindal Stainless Limited (JSL) Wins 95 Gold and 6 Silver Awards at QCFI Conventions 2026
-
Communication Services2 days agoMatrimony.com Limited Q2 FY26: PAT Growth of 167% Y/y
-
Auto Parts2 days agoMrf Limited (NSE: MRF) Q2 FY27: Profit Up 44%, Revenue Rises 17%
